FindTrial
Sign In

Research on supporting technology of anti-inflammatory treatment decision-making of macular edema based on Reinforcement Learning

Research on supporting technology of anti-inflammatory treatment decision-making of macular edema based on Reinforcement Learning

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000035610
Enrollment
Unknown
Registered
2020-08-15
Start date
2020-12-01
Completion date
Unknown
Last updated
2020-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Macular Edema

Interventions

Case series:Nil

Sponsors

Shanghai General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The patients with macular edema confirmed by fundus examination should be given anti-inflammatory treatment according to the doctor's judgment.

Exclusion criteria

Exclusion criteria: Patients with macular edema, pregnant women and lactation patients, children, mental disorders and cognitive impairment were excluded.

Design outcomes

Primary

MeasureTime frame
Visual Acuity;Number of Hyperreflective Foci;Volume of Subretinal Detachment;—

Secondary

MeasureTime frame
Image feature information (texture information);Distribution of Hyperreflective Foci;—

Countries

China

Contacts

Public ContactYupeng Xu

Shanghai General Hospital

kevinxyp@163.com+86 15921111582

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026